The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing

NCT01128556 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Histamine Responsive Allergy Patients

Interventions

DRUG: Bepreve
DRUG: Refresh Tears

Sponsor

North Texas Institute for Clinical Trials